BR9910185A - Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana - Google Patents

Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana

Info

Publication number
BR9910185A
BR9910185A BR9910185-8A BR9910185A BR9910185A BR 9910185 A BR9910185 A BR 9910185A BR 9910185 A BR9910185 A BR 9910185A BR 9910185 A BR9910185 A BR 9910185A
Authority
BR
Brazil
Prior art keywords
compound
treatment
risk
patient suffering
mycobacterial disease
Prior art date
Application number
BR9910185-8A
Other languages
English (en)
Inventor
Meenakshi Balganesh
Kantharaj Ethiraj
Babita Ganguly
Ramachandran Janakiraman
Parvinder Kaur
Rangarao Kajipala
Santosh Nandan
Ramanujulu Pandi Murugappan
Narayanan Ramachandran
Balasubramanian Venkataraman
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR9910185A publication Critical patent/BR9910185A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE UM COMPOSTO, E, PROCESSO PARA O TRATAMENTO DE UM PACIENTE QUE SOFRE DE, OU EM RISCO DE, UMA DOENçA MICOBACTERIANA" Uso de um composto com a fórmula geral (I), onde x é 0 ou 1; R¹, R², R³ e R^ 4^ possuem definições proporcionadas na descrição, ou um sal ou solvato farmaceuticamente aceitáveis do mesmo, na fabricação de um medicamento para uso no tratamento de uma doença micobacteriana.
BR9910185-8A 1998-05-05 1999-05-03 Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana BR9910185A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors
PCT/SE1999/000732 WO1999065483A1 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Publications (1)

Publication Number Publication Date
BR9910185A true BR9910185A (pt) 2001-01-09

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910185-8A BR9910185A (pt) 1998-05-05 1999-05-03 Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana

Country Status (14)

Country Link
US (1) US6476053B1 (pt)
EP (1) EP1075261B1 (pt)
JP (1) JP2002518324A (pt)
KR (1) KR20010043322A (pt)
CN (1) CN1201735C (pt)
AT (1) ATE322898T1 (pt)
AU (1) AU739140B2 (pt)
BR (1) BR9910185A (pt)
CA (1) CA2330667A1 (pt)
DE (1) DE69930844T2 (pt)
IL (1) IL139144A0 (pt)
NO (1) NO20005548L (pt)
NZ (1) NZ507620A (pt)
WO (1) WO1999065483A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037314A2 (en) 2001-11-01 2003-05-08 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
CA2619262A1 (en) * 2005-08-19 2007-02-22 Astrazeneca Ab Pyrazolone derivatives for the treatment of tuberculosis
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
WO2010063617A1 (de) * 2008-12-04 2010-06-10 Basf Se Mischungen aus itaconsäure oder itaconsäurederivaten und primären aminen zur herstellung von 1,3- und 1,4-alkylmethylpyrrolidonen
CN108601855B (zh) * 2015-12-23 2021-04-27 汉高股份有限及两合公司 金属加工流体
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
WO2019108047A2 (ko) * 2017-12-01 2019-06-06 주식회사 굳티셀 탈모의 예방 또는 치료용 조성물
CN119569636B (zh) * 2024-10-22 2026-03-27 南京吉星生物技术开发有限公司 一种吡咯啉二酮类化合物及其制备方法和杀菌剂应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
NZ507620A (en) 2003-05-30
IL139144A0 (en) 2001-11-25
DE69930844T2 (de) 2006-12-28
WO1999065483A1 (en) 1999-12-23
CN1308532A (zh) 2001-08-15
NO20005548D0 (no) 2000-11-03
CA2330667A1 (en) 1999-12-23
EP1075261A1 (en) 2001-02-14
AU4304199A (en) 2000-01-05
US6476053B1 (en) 2002-11-05
EP1075261B1 (en) 2006-04-12
ATE322898T1 (de) 2006-04-15
AU739140B2 (en) 2001-10-04
KR20010043322A (ko) 2001-05-25
CN1201735C (zh) 2005-05-18
JP2002518324A (ja) 2002-06-25
DE69930844D1 (de) 2006-05-24
NO20005548L (no) 2000-12-04

Similar Documents

Publication Publication Date Title
BR9812501A (pt) Processo para a preparação de um pentopiranosilnucleosìdeo
BR0007504A (pt) Composto triazol, fármaco, e, uso de pelo menos um composto
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
BR0111034A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
BR9910928A (pt) Composto, processo para a prepará-lo, uso do mesmo, formulação, e, processo para a profilaxia e/ou tratamento de condições clinicas associadas com resistência a insulina
NO870241L (no) Hypoglykemiske tiazolidindioner.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
NO922380D0 (no) Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
BR0012901A (pt) Medicamentos de ß - carbolina
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
BR9813208A (pt) Antagonista receptor de vitronectina
BR0113590A (pt) 7-oxo-piridopirimidinas
DE69814394D1 (de) Verwendung von levobupivacain
ITMI913171A0 (it) Soluzione di farmaci con stabilita' aumentata a senza effetto dannoso sui tessuti e procedimento per la loro preparazione
EP0369887A3 (fr) Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs
BR9711414A (pt) Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto
KR960006915A (ko) 췌장염의 치료 조성물
BR0011578A (pt) Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
SE9400447D0 (sv) New compounds

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/4015, A61K 31/4035, A61K 4465, A61K 31/45, A61K 31/454, A61P 31/06, C07D 211/88, C07D 207/404, C07D 207/408, C07D 207/448, C07D 209/48

Ipc: A61K 31/4015 (2008.04), A61K 31/4035 (2008.04), A6

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.